Theralase Technologies Inc (TLTFF)

[Anesthesia 2007]

In light of the statement in this PR about early commercial adoption if early Phase 2 results are positive, how many patients do you think they will have to get through before supplying “early” results? How is it possible to have early commercial adoption without full FDA, Canadian, or international approvals after a full phase 2 study is completed?
Does this come back to the new law passed in the US that allows the use of non-approved treatments for terminal patients with no other choices, or is there something else I’m missing?